Latest Conference Articles

After partial hepatectomy, the liver does not need an environment rich in microbes and microbial products to regenerate, a Swiss team reports. The finding contradicts earlier studies.

You can tell a lot about a person by the way they walk, the way they sit, and the way they conduct themselves in general. Recent research has also shown that signs of potential health issues can be seen when watching a person move.

French researchers found that patients with hepatitis C infections due to genotypes 4 and 5 did well on a combination of ledipasvir and sofosbuvir (Harvoni/Gilead.) The drug got FDA approval last year but since then there have been few reports on how well it is doing in the real world.

When it comes to headaches many people are familiar with the pain of migraines but cluster headaches can have just as much if not more of an impact on a person's life.

A new antiviral combination that shows dramatic results in getting a response from patients with both chronic kidney failure and hepatitis C is proving versatile.

Video Interview: Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, spoke about several drug candidates under review working to improve outcomes of liver blood tests at The International Liver Congress 2015, Vienna, Austria.

Translational medicine should work for many patients with liver cancer, a French research team reported this morning at the 2015 International Liver Congress.

In this video interview, Palak Trivedi, BSc, MBBS, MRCP, from the University of Birmingham Centre for Liver Research, United Kingdom, discussed the implications his research findings have for IBD patients at The International Liver Congress 2015 in Vienna, Austria.

So far there are no approved pharmaceuticals for treating a common liver disease, non-alcoholic steatohepatitis (NASH). But in a second encouraging drug development reported at the International Liver Congress in Vienna, Austria this morning, Austria, researchers said they like what they see in a trial of Liraglutide (Saxenda/ NovoNordisk).

An investigational diabetes drug called remogliflozin etabonate appears to also show promise for treating a common liver disease, non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).

High levels of vitamin D3 appear to induce weight gain in mice that were fed a high-fat diet, a research team found.

Many studies have looked at the link between vitamin D deficiency and liver disease. A Korean team recently examined whether vitamin D deficiency played a pivotal role in abnormal liver enzymes.

The intracellar lipid deposition, mitrochondrial dysfunction, and insulin resistance associated with non-alcoholic fatty liver disease is likely regulated by microRNAs, particularly in obese patients.

Patients with severe cirrhosis, those who are waiting for a liver transplant, or have recurrent hepatitis C infection following treatment are desperately ill. Researchers at the 2015 International Liver Congress reported that a fixed dose combination of ledipasvir/sofosbuvir given in combination with ribavirin helped many of these patients, according to the results from the SOLAR 2 trial.

To the legal and criminal justice system, people with behavioral-variant frontotemporal dementia (bvFTD) are responsible for any moral or legal transgressions questions that assumption.

Stroke episodes are ideally suited for assessing the concept of value-based care, a Kentucky team argues.

With all the focus on the hazards of concussion brain injury in professional US football, Australian researchers decided it was time to take a look at the risks in rugby.

A diet rich in fish, green leafy vegetables, nuts and whole grains appears to lead to an increase in brain volume.

Stroke creates language deficits related to brain tissue damaged directly by lesions in cortical and subcortical regions. Disruptions of white matter connectivity also affect multiple domains of behavior and cognition.

Huntington's Disease (HD) is an autosomal dominant progressive neurodegenerative disorder. In addition to the central nervous system disturbance the ailment causes, there is increasing evidence the genetic abnormality also affects peripheral organs and tissues.

Patients with multiple sclerosis (MS) often have sensitivity to heat that worsens their symptoms. In earlier studies with MS patients, a device system that cools body temperature by chilling one palm proved useful in helping them walk faster and longer. But patients need to be motivated to use it successfully.

Results from one module of the CaMEO (Chronic Migraine Epidemiology and Outcomes) study show that patients with chronic migraine are not the only ones who suffer.

An estimated 11,000 attendees from 105 countries are converging in Vienna, Austria for the 50th International Liver Congress, hosted by the European Association for the Study of the Liver (ILC/EASL). Some 200 journalists -- including a team from MD Magazine--are on hand to report the news. Eagerly awaited trials include those of two drugs that show promise for treating a common liver disease associated with obesity, known medically as non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).

Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, shared his fascination with the enigma that is primary sclerosing cholangitis.

While skin biopsies can give insight to epidermal innervation after a nerve injury, properly identifying pain becomes more challenging in those with neuropathy.

New evidence has made it easier to differentiate between multiple sclerosis and vanishing white matter disease, conditions that can show considerable similarities.

Giving up bread may not help cure every celiac disease symptom, but researchers found a relationship between a gluten-free diet and a reduction in headache frequency.

A lot is known about the benefits of Natalizumab in the treatment of MS patients, but there is also a known risk of patients developing progressive multifocal leukoencephalopathy. Finding a balance between the two conditions was the focus of recent research.

Patients with Parkinson's disease frequently look for treatments that physicians consider alternative or complementary therapies.

Stepping out into the sun may be more important than ever, especially for patients with multiple sclerosis.